GPA33 and osteosarcoma: GD2-BsAb and HER2-BsAb suppressed osteosarcoma growth compared to negative controls (GPA33-BsAb) (P = 0.0005 for GD2-BsAb and P = 0.10 for HER2-BsAb, respectively).